chr6-150143304-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_030949.3(PPP1R14C):āc.112A>Gā(p.Ser38Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000212 in 1,570,442 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_030949.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PPP1R14C | NM_030949.3 | c.112A>G | p.Ser38Gly | missense_variant | 1/4 | ENST00000361131.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PPP1R14C | ENST00000361131.5 | c.112A>G | p.Ser38Gly | missense_variant | 1/4 | 1 | NM_030949.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 151998Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000623 AC: 12AN: 192616Hom.: 0 AF XY: 0.0000927 AC XY: 10AN XY: 107874
GnomAD4 exome AF: 0.000225 AC: 319AN: 1418444Hom.: 0 Cov.: 34 AF XY: 0.000229 AC XY: 161AN XY: 704396
GnomAD4 genome AF: 0.0000921 AC: 14AN: 151998Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74256
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2022 | The c.112A>G (p.S38G) alteration is located in exon 1 (coding exon 1) of the PPP1R14C gene. This alteration results from a A to G substitution at nucleotide position 112, causing the serine (S) at amino acid position 38 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at